Shumway, Norman E.; Lower, Richard R.; Angell, William M.
May 1966
Angiology;May1966, Vol. 17 Issue 5, p289
Academic Journal
The present status of heart transplantation is entirely that of a laboratory experiment, although long term survival is possible with intermittent immune suppressant therapy. The future of heart replacement by means of tissue transplants appears to depend on the development of some kind of banking system, which in turn must be preceded by improved methods for resuscitating cadaver hearts. The supply of suitable heterologous hearts is limited, and the homograft must come from a stockpile of resuscitated cadaver hearts or possibly from the hopelessly ill donor whose death is determined by criteria unrelated to the circulatory system.


Related Articles

  • Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation. Kurian, Kizhake C.; Addisu, Anteneh // Recent Patents on Cardiovascular Drug Discovery;Nov2009, Vol. 4 Issue 3, p187 

    Cardiac transplantation is a time-honored therapy for end stage heart disease for a select group of patients. The advances in recent years have increased mean survival to 12 and 13 years. The probability of survival after heart transplantation at one, five and ten years are 80%, 70% and 60%...

  • Christiaan Barnard. Ballaro, Beverly // Christiaan Barnard;7/1/2006, p1 

    The article presents a biography of South African surgeon Christiaan Barnard who performed the world's first human heart transplant in 1967. The article also discusses the development of heart transplantation surgery during the Second World War and the 1950s. Barnard received a medical degree...

  • Strategies to Prevent Cellular Rejection in Pediatric Heart Transplant Recipients. Denfield, Susan W. // Pediatric Drugs;2010, Vol. 12 Issue 6, p391 

    Despite more than 40 years' experience in pediatric heart transplantation, cellular rejection remains a significant cause of morbidity and mortality. In this review, strategies and agents to prevent acute cellular rejection are discussed. Strategies to prevent rejection are divided into two...

  • Immunosuppressants.  // Reactions Weekly;9/15/2007, Issue 1169, p18 

    The article describes the case of two female organ transplant recipients who developed nephrogenic systemic fibrosis (NSF) during treatment with immunosuppressants. A 19-year-old woman developed acute kidney injury attributed to acute tubular necrosis following a heart surgery in August 2006,...

  • Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation. Bengel, Frank M.; Ueberfuhr, Peter; Schiepel, Nina; Nekolla, Stephan G.; Reichart, Bruno; Schwaiger, Markus // New England Journal of Medicine;9/6/2001, Vol. 345 Issue 10, p731 

    Background: Late after cardiac transplantation, limited reinnervation of the transplanted heart may occur, but little is known about the effect of reinnervation on cardiac function and exercise performance. Methods: We quantified the extent of myocardial reinnervation noninvasively in 29...

  • transplantation.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2361 

    An encyclopedia entry for "transplantation" is presented. It refers to the grafting of living tissue from its normal position to another site or the transplantation of organs, such as heart and lungs, or tissue from one person to another. In dentistry, the term is used to the transfer of a tooth...

  • Prophylactic Cholecystectomy in Transplant Patients: A Decision Analysis Kao, Lillian S.; Flowers, Christopher; Flum, David R. // Journal of Gastrointestinal Surgery;Sep2005, Vol. 9 Issue 7, p965 

    Prophylactic laparoscopic cholecystectomy should be performed in solid organ transplant patients with asymptomatic cholelithiasis. Modeled, decision analytic techniques were used to evaluate the different management strategies for asymptomatic cholelithiasis in cardiac and pancreas/renal...

  • Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Hunt; Deng, Mario C; De Meester, Johan M J; Smits, Jacqueline M A; Heinecke, Joachim; Scheld, Hans H // BMJ: British Medical Journal (International Edition);09/02/2000, Vol. 321 Issue 7260, p540 

    Objective: To determine whether there is a survival benefit associated with cardiac transplantation in Germany.Design: Prospective observational cohort study.Setting: All 889 adult patients listed for a first heart transplant in Germany in 1997.Main outcome measure: Mortality, stratified by...

  • Current Status of Cardiac Transplantation and Left Ventricular Assist Devices. Frazier, O. H. // Texas Heart Institute Journal;2010, Vol. 37 Issue 3, p319 

    The article discusses the trend in cardiac transplantation and developments in left ventricular assist devices in the U.S. market as of June 2010. The first successful heart transplantation was reportedly performed in April 1968. The author shares that between 1982 and 1992, he performed 138...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics